World Library  
Flag as Inappropriate
Email this Article
 

Uppsala Monitoring Centre

The Uppsala Monitoring Centre (UMC), located in Collaborating Centre for International Drug Monitoring. The UMC works by collecting, assessing and communicating information from member countries' national pharmacovigilance programs in regard to the benefits, harm, effectiveness and risks of drugs.[1]

Contents

  • Background 1
  • WHO Programme key dates 2
  • See also 3
  • References 4
  • External links 5

Background

Since 1978, responsibility for managing the WHO Programme for International Drug Monitoring has been carried by the UMC. In the early years the staff consisted of just three pharmacists based at the Swedish Medical Products Agency (Läkemedelsverket); currently over 80 staff work in central Uppsala. The founding chairman and acting Director was Professor Åke Liljestrand. From 1990 to 2009 the Director was Professor Ralph Edwards.[2] Since September 2009 Dr. Marie Lindquist is the Director. The Chief Medical Officer is Dr. Pia Caduff and the Head of Research is Dr. Niklas Norén.

The work of the UMC is:

  • To co-ordinate the WHO Programme for International Drug Monitoring and its more than 100 member countries.
  • To collect, assess and communicate information from member countries about the benefits, harms and risks of drugs and other substances used in medicine to improve patient therapy and public health worldwide
  • To collaborate with member countries in the development and practice of the science of pharmacovigilance.

The main focus and source of data in WHOART (adverse reaction terminology)[4] – with a bridge to the MedDRA terminology, tools for searching in the database, and a program for case report management, VigiFlow.[5]

The UMC's research covers mainly three areas: data-driven discovery (especially statistical techniques), dis-proportionality analyses, interaction detection, patterns and duplicate case detection), safety surveillance and signaling (among which drug dependence and pediatric use) and benefit—risk analysis.[6]

The centre has been active in presenting research in the medical literature which has included some seminal works in the field.[6] The Uppsala centre has also published books in the field of drugs safety including a regular newsletter.[5] In 2010 the 2nd edition of a crisis management guide was published, entitled 'Expecting the Worst'.[7]

The UMC's role in drug safety has not been without controversy for both medicines agencies and pharmaceutical companies, despite an open approach willing to engage with many parties in the pharmaceutical world. They are closely involved in outreach to developing countries and other areas where pharmacovigilance is not yet handled.[6]

WHO Programme key dates

  • 1968 WHO Programme established. International ADR terminology and drug dictionary
  • 1969 Definition of ADR
  • 1978 Operations transferred to the UMC; setting-up of relational ADR database. Regular WHO Programme member meetings
  • 1981 Computerised version of WHO Drug Dictionary available to all
  • 1982 ATC classification coding of all medicinal products
  • 1985 International expert review panel created
  • 1991 On-line WHO database search programme available to national centres
  • 1991 Definitions of adverse event, side effect and causality assessment terms
  • 1993 Windows-based client server program for online database searches
  • 1993 Regular training and educational activities
  • 1994 Methodology for use of denominator data for calculation of ADR reporting rates
  • 1997 Knowledge-detection tool for automated signal detection (BCPNN)
  • 1997 Promotion of communication as a necessary discipline in pharmacovigilance : the 'Erice Declaration'
  • 1998 Internet discussion group for national centres
  • 2001 Start of Vigibase Online project (now VigiFlow)
  • 2002 New database system (Vigibase)
  • 2004 Pattern recognition using the BCPNN on health databases to find safety information.
  • 2005 Launch of expanded WHO Drug Dictionary with additional data fields; agreement with IMS Health to increase information in the dictionary
  • 2010 100th country joins the WHO Programme for International Drug Monitoring
  • 2012 Over 7 million adverse reaction reports in the WHO ICSR database

See also

References

  1. ^ Drug Benefits and Risks – International Textbook of Clinical Pharmacology (2nd edition). Van Boxtel C, Santoso B and Edwards IR, eds. IOS Press, Amsterdam, 2008.
  2. ^ Spross Å. Uppsala leder forskning om biverkningar. Uppsala Nya Tidning, 28 December 2008.
  3. ^ Lindquist M. Vigibase, the WHO Global ICSR Database System: Basic Facts. Drug Information Journal, 2008, 42:409–419.
  4. ^ US National Library of Medicine, 2010 entry for UMC, retrieved 28 January 2014
  5. ^ a b Textbook of Pharmacovigilance (Chapter 11). Ed: SK Gupta. Jaypee Brothers Medical Publishers, New Delhi, 2011.
  6. ^ a b c Telerx website; description and critique of the Uppsala Monitoring Centre, retrieved 28 January 2014.
  7. ^ Clark D. Review: Expecting the Worst – a publication from the Uppsala Monitoring Centre. Drug Safety 2010; 33(12):1135–36.

External links

  • [1], Uppsala Monitoring Centre home
  • [2], Uppsala Reports is the UMC's regular news bulletin for everyone concerned with the issues of pharmacovigilance.
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.